Extracted from this filing and checked against the source text.
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 0.9
American Oncology Network, Inc. incurred loan of up to $700,000 with Digital Transformation Sponsor LLC at no interest maturing upon the earlier of (i) the date of the consummation of the Company’s initial business combination and (ii) the date of the liquidation of the Company.
- Instrument
- loan
- Principal
- up to $700,000
- Counterparty
- Digital Transformation Sponsor LLC
- Rate
- no interest
- Maturity
- upon the earlier of (i) the date of the consummation of the Company’s initial business combination and (ii) the date of the liquidation of the Company
- Event
- incurrence
Exact text from the filing
LLC (the “Sponsor”) entered into a promissory note with Digital Transformation Opportunities Corp. (“DTOC” or the “Company”), providing for an aggregate amount of loans up to $700,000 to fund the Company’s operating expenses (the “Working Capital Facility”). The Working Capital Facility bears no interest and all unpaid principal under the Working Capital
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
American Oncology Network, Inc. entered into Working Capital Facility with Digital Transformation Sponsor LLC valued at up to $700,000 (effective 2023-05-01).
- Action
- entry
- Agreement
- credit facility
- Counterparty
- Digital Transformation Sponsor LLC
- Value
- up to $700,000
- Effective
- 2023-05-01
Exact text from the filing
On May 1, 2023, Digital Transformation Sponsor LLC (the “Sponsor”) entered into a promissory note with Digital Transformation Opportunities Corp. (“DTOC” or the “Company”), providing for an aggregate amount of loans up to $700,000 to fund the Company’s operating expenses (the “Working Capital Facility”).
View on SEC.gov